Alglucerase

In the US, Alglucerase (alglucerase systemic) is a member of the drug class lysosomal enzymes and is used to treat Gaucher Disease.

US matches:

• Alglucerase


• Alglucerase Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A16AB01

CAS registry number (Chemical Abstracts Service)

0143003-46-7

Chemical Formula

C2532-H3854-N672-O711-S16

Molecular Weight

55600

Therapeutic Category

Enzyme, replacement therapy

Chemical Name

Glucosylceramidase (human placenta isoenzyme protein moiety reduced)

Foreign Names

• Alglucerasum (Latin)
• Alglucerase (German)
• Alglucérase (French)
• Alglucerasa (Spanish)

Generic Names

• Alglucerase (OS: USAN, BAN)
• Alglucérase (OS: DCF)
• AD900 (IS)

Brand Names

• Ceredase
  Genzyme, Israel; Genzyme, United States

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.